- Home
- WRAP vs TNYA Comparison
WRAP vs TNYA Comparison
Compare WRAP & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRAP
- TNYA
- Stock Information
- Founded
- WRAP 2016
- TNYA 2016
- Country
- WRAP United States
- TNYA United States
- Employees
- WRAP N/A
- TNYA N/A
- Industry
- WRAP Ordnance And Accessories
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- WRAP Industrials
- TNYA Health Care
- Exchange
- WRAP Nasdaq
- TNYA Nasdaq
- Market Cap
- WRAP 101.6M
- TNYA 113.6M
- IPO Year
- WRAP N/A
- TNYA 2021
- Fundamental
- Price
- WRAP $1.71
- TNYA $0.57
- Analyst Decision
- WRAP
- TNYA Strong Buy
- Analyst Count
- WRAP 0
- TNYA 6
- Target Price
- WRAP N/A
- TNYA $8.60
- AVG Volume (30 Days)
- WRAP 133.6K
- TNYA 6.1M
- Earning Date
- WRAP 03-31-2025
- TNYA 03-10-2025
- Dividend Yield
- WRAP N/A
- TNYA N/A
- EPS Growth
- WRAP N/A
- TNYA N/A
- EPS
- WRAP N/A
- TNYA N/A
- Revenue
- WRAP $4,231,000.00
- TNYA N/A
- Revenue This Year
- WRAP N/A
- TNYA N/A
- Revenue Next Year
- WRAP N/A
- TNYA N/A
- P/E Ratio
- WRAP N/A
- TNYA N/A
- Revenue Growth
- WRAP N/A
- TNYA N/A
- 52 Week Low
- WRAP $1.21
- TNYA $0.39
- 52 Week High
- WRAP $2.58
- TNYA $5.25
- Technical
- Relative Strength Index (RSI)
- WRAP 35.57
- TNYA 37.17
- Support Level
- WRAP $1.95
- TNYA $0.62
- Resistance Level
- WRAP $2.21
- TNYA $0.69
- Average True Range (ATR)
- WRAP 0.18
- TNYA 0.07
- MACD
- WRAP -0.04
- TNYA 0.02
- Stochastic Oscillator
- WRAP 24.71
- TNYA 6.69
About WRAP Wrap Technologies Inc.
Wrap Technologies Inc offers public safety technologies and services. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.